Is there a guideline on whether to measure serum bile acids in a fasting sample versus a random (non‑fasting) blood draw when evaluating cholestasis?

Bile Acid Testing for Cholestasis: Fasting vs. Non-Fasting

For intrahepatic cholestasis of pregnancy (ICP), random (non-fasting) bile acid measurement is recommended and typically more convenient, as the differences between fasting and random results are small and most ICP studies used random samples 1. For non-pregnant adults with chronic cholestatic liver disease, fasting bile acid measurement is the standard approach 2.

Context-Specific Recommendations

In Pregnancy (ICP Evaluation)

The most recent high-quality guidelines explicitly address this question:

• Random/non-fasting samples are acceptable and preferred for practical reasons 1
• The SMFM 2021 guidelines state: "Although the bile acid level can be affected by a postprandial state and fasting bile acid measurements are often performed, the differences between the random and fasting results are small. Samples analyzed in most reports of ICP in pregnancy were obtained at random. Random bile acid levels can therefore be used to diagnose ICP and are typically more convenient for the patient and practitioner" 1

However, emerging evidence suggests nuance:

The 2023 EASL pregnancy guidelines provide pregnancy-specific reference ranges that differ by fasting status 2:

• Fasting bile acids: 0-6 μmol/L (non-pregnant) vs. 0-10 μmol/L (3rd trimester non-fasting)
• Non-fasting bile acids: 0-19 μmol/L (2nd trimester) to 0-10 μmol/L (3rd trimester)

The guidelines explicitly note: "Non-fasting bile acid concentrations preferable in pregnancy" 2

In Non-Pregnant Adults

For chronic cholestatic liver disease evaluation:

• Fasting measurement is the standard 2
• The 2023 EASL guidelines specify: "fasting measurement is recommended in non-pregnant individuals" 2
• This applies to conditions like primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC)

Important Caveats

Timing Considerations for Liver Stiffness (Related Context)

While not directly about bile acids, the 2021 EASL guidelines on non-invasive tests emphasize that minimum 3 hours fasting is required for liver stiffness measurement to avoid overestimation 3. This principle of meal effects on hepatic measurements is relevant.

Diagnostic Accuracy Trade-offs

Recent research reveals important limitations:

• Postprandial bile acids are significantly higher than fasting values in both healthy pregnancy and ICP 4, 5
• Using fasting samples in symptomatic pregnant women resulted in 23% fewer diagnoses of cholestasis compared to non-fasting values 4
• Fasting measurements have higher specificity but lower sensitivity for mild ICP (sensitivity <30% for mild disease) 5
• For severe ICP (≥40 μmol/L), fasting identified only 9% of cases while non-fasting detected >91% 5

Clinical Algorithm

For suspected ICP:

1. Obtain non-fasting bile acid level initially (more sensitive, practical)
2. Use threshold of ≥19 μmol/L for diagnosis (based on updated reference ranges) 5
3. If borderline or monitoring severity, consider both fasting and postprandial measurements 6

For chronic cholestatic liver disease (non-pregnant):

1. Obtain fasting bile acid level (standard approach)
2. Ensure minimum 3-hour fast
3. Avoid measurement during acute inflammation, cholangitis, or venous congestion 3

Common Pitfalls to Avoid

• Don't use the traditional 10 μmol/L threshold universally - this may be too low for non-fasting samples in pregnancy 1, 5
• Don't assume fasting is always better - in pregnancy, fasting samples miss high-risk cases 5
• Don't ignore timing relative to meals - bile acids show marked postprandial elevation 7
• Don't mix fasting and non-fasting reference ranges - they are not interchangeable 2, 6

The evidence shows a clear divergence between pregnancy and non-pregnancy contexts, with pregnancy guidelines favoring practical non-fasting measurement while non-pregnant adult evaluation maintains fasting as standard.